Replay coming soon
On demand
Advance drug discovery biology with CAS BioFinder®
Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.
This webinar demonstrates how CAS BioFinder supports end-to-end discovery biology workflows from disease landscape assessment through target validation and candidate optimization.
With real-world examples, we’ll show how to connect disparate data types (disease biology, targets, pathways, chemistry, and clinical insights) into a single, defensible workflow that accelerates hypothesis generation and reduces downstream risk.
The session will highlight how scientists can move from fragmented evidence to actionable decisions with confidence.
What you will learn
- How to contextualize a disease area by integrating literature, drug landscape, biomarkers, and unmet need into a single, navigable view
- How to identify and validate high-confidence targets by linking proteins, pathways, and disease associations with supporting evidence
- How to assess developability and avoid undruggable targets by bringing ADME, metabolism, and toxicology data into the workflow early
- How to translate biological insights into development strategy by analyzing clinical activity, adverse events, and competitive therapeutics (including biologics)
Registration is closed. The webinar recording will be viewable in 48 hours.